Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma Limited has filed its financial results for the quarter and nine months ended December 31, 2025 with the stock exchange. The announcement is only a compliance filing confirming that results have been submitted, and does not include the actual numbers or a press release. Investors will need to refer to the detailed results PDF filed separately for revenue, profit, and segment performance. No management commentary or guidance is included in this filing.
Neutral on its own — this is a routine regulatory disclosure. Stock reaction will depend entirely on the actual numbers in the results PDF, which are not part of this announcement.